Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up to $16.65

Tectonic Therapeutic (NASDAQ:TECX)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $16.65, but opened at $17.36. Tectonic Therapeutic shares last traded at $17.19, with a volume of 511 shares trading hands.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. TD Cowen initiated coverage on shares of Tectonic Therapeutic in a research note on Monday, June 24th. They issued a “buy” rating on the stock. Piper Sandler began coverage on shares of Tectonic Therapeutic in a report on Wednesday, June 26th. They set an “overweight” rating and a $76.00 target price for the company.

Tectonic Therapeutic Stock Down 0.3 %

The firm has a market capitalization of $768.97 million, a P/E ratio of 24.91 and a beta of 2.63.

Tectonic Therapeutic (NASDAQ:TECX) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter. On average, equities analysts predict that Tectonic Therapeutic will post -5 EPS for the current year.

About Tectonic Therapeutic

Avrobio, Inc is a bio-technology company. It develops step-change cell and gene therapies for the treatment of cancer and rare disease. The company operates primarily in the United States and Canada. Avrobio, Inc is based in MA, United States.